CEO Sports Hobby and Firms' Tax Aggressiveness
The Journal of the American Taxation Association · 01.03.2022 · 44 (1) · 123-153
DOI: 10.2308/jata-19-038 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of the American Taxation Association, online erschienen am 02.07.2021. Verfasst von Shuqing Luo und 3 weiteren Autor:innen. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 79 Literaturangaben.
Abstract (Originalsprache)
Recent accounting research suggests that individual executives play a significant role in shaping a firm's tax planning. Building on psychology research that finds sports interests reflect an individual's risk-taking preferences, we develop a novel measure of innate and non-pecuniary CEO risk attitudes based on the riskiness of CEOs' sports hobbies and examine whether the measure is associated with corporate tax aggressiveness. We find that firms managed by CEOs with riskier sports hobbies are more aggressive in their tax planning. This association is more pronounced for CEOs with greater financial incentives and greater power in making decisions. Our results are robust to using alternative measures of CEO sports risks, and after accounting for the self-selection of the disclosure of CEO sports hobbies. Data Availability: Public sources cited in the paper. JEL Classifications: H26; M41; G41; G34.
Zitieren
APA
Luo, S., Shevlin, T., Shi, L., & Shih, A. (2022). CEO Sports Hobby and Firms' Tax Aggressiveness. The Journal of the American Taxation Association, 44(1), 123-153. https://doi.org/10.2308/jata-19-038
Vancouver
Luo S, Shevlin T, Shi L, Shih A. CEO Sports Hobby and Firms' Tax Aggressiveness. The Journal of the American Taxation Association. 2022;44(1):123-153. doi:10.2308/jata-19-038
BibTeX
@article{Luo2022,
author = {Luo, Shuqing and Shevlin, Terry and Shi, Lirong and Shih, Aimee},
title = {CEO Sports Hobby and Firms' Tax Aggressiveness},
journal = {The Journal of the American Taxation Association},
year = {2022},
volume = {44},
number = {1},
pages = {123--153},
doi = {10.2308/jata-19-038}
}
EUVIMED